News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Edificio Node I y Node II de Kadans
Kadans Science Partner is taking part in Photonics 2026 with its Node I and Node II technology facilities in Málaga
Access to innovation · International · Financing
The company will have a stand at Photonics 2026, where it will present its new Node I centre,…
Partners - KADANS SCIENCE PARTNER 1 SP S.L.
Foto de Nuria Marcos e Ivan Sempere
PONS IP appoints Iván Sempere as Deputy Chief Executive Officer to accelerate its global growth strategy
Access to innovation · International · Talento
With an extensive professional, institutional and academic background, Sempere joins the…
Partners - PONS IP
Foto del equipo del FUAM y UAM
Driving medicine that transforms clinical data into evidence with AI
Healthcare · Access to innovation · Digitalization
The Autonomous University of Madrid (UAM) will host the first edition of BSD Data Days on 15…
Partners - BIOGA
Logo de Neural Omega y foto del CEO Pedro Bernardo
Neural Omega to present its full molecular mimicry pipeline at BioSpain 2026
Healthcare · Access to innovation · Drug discovery
From clinical data to drug discovery: Madrid-based biotech Neural Omega will make its international…
Partners - NEURAL OMEGA
Edificio Oryzon
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat combination with gilteritinib
Healthcare · Drug discovery · Innovative drugs
Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination…
Partners - Oryzon Genomics
Director General de INCLIVA Vicente de Juan Martín
#NewAseBioMember | "AseBio is the main hub of the Spanish biotechnology ecosystem"
Corporate
Meet our new AseBio member, INCLIVA. We spoke with Vicente de Juan, Managing Director.
AseBio - INCLIVA
Científico de Certest realizando pruebas
Almirall and Certest Biotec enter strategic research collaboration and licensing agreement
Healthcare · Rare diseases · Innovative drugs
Almirall and Certest Biotec, S.L., through its pharmaceutical division, Certest Pharma, have…
Partners - CERTEST BIOTEC
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and Molecular Glue discovery
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and Molecular Glue discovery
Healthcare · Drug discovery · Innovative drugs
Celtarys Research has expanded its drug discovery portfolio into Targeted Protein Degradation (TPD…
Partners - Celtarys Research
Foto en El Escorial curso RAM de MSD
Experts discuss prevention as a strategy to combat antibiotic resistance
Healthcare · Access to innovation · Antibiotic resistance
The summer course “Antibiotic Resistance and One Health” addressed surveillance, therapeutic…
Partners - MSD